Fulminant hepatic failure (FHF) is often accompanied by a myriad of neurologic complications, which are associated with high morbidity and mortality. Although appropriate neuromonitoring is recommended for early diagnosis and to minimize secondary brain injury, individuals with FHF usually have a high chance of coagulopathy, which limits the ability to use invasive neuromonitoring. Jugular bulb venous oxygen saturation (JvO 2 ) monitoring is well known as a surrogate direct measures of global brain oxygen use. We report the case of a patient with increased intracranial pressure due to FHF, in which JvO 2 was used for appropriate brain oxygen monitoring.
Editorial
.
In addition to medical supportive care, 11.7% hypertonic saline (replacing mannitol) was administered to control brain swelling. Moreover, targeted temperature management was initiated at 35°C and further decreased to 33°C, to best control ICP crisis. Furthermore, to monitor global brain oxygen levels, JvO 2 monitoring was initiated. The right internal jugular vein was cannulated cephalad with a pediatric central venous catheter and advanced upward (Fig. 1C) . During the monitoring time, JvO 2 fluctuated between 45% and 75% and did not increase above 85%, suggesting that brain swelling was mostly osmotic in origin rather than due to hyperperfusion (Fig. 2) . For adequate sedation and shivering prevention, remifentanil was initiated at a rate of 0.02 µg/kg/min and subsequently adjusted based on neurological status. On day 9, pupillary light reflex was improved bilaterally and neurologic status improved from a GCS score of 6 to 8. AST and ALT levels were improved to 305 IU/L, and 1160 IU/L, respectively, and prothrombin time was 21.1 s (41%). On day 11, the patient could trace a moving object. Followup brain CT scan showed decreased brain swelling.
Prothrombin time was improved to 14.8 s (65%). JvO 2 gradually increased to 70-75% with a cessation of sedation (Fig. 2) . After confirming a decrease of brain edema, a slow but controlled rewarming (0.05 °C/h) was initiated and targeted temperature management was stopped on day 12. Meanwhile, bolus doses of hyperosmotic agents were gradually reduced. On day 25, the patient could follow simple commands, such as closing their eyes or opening their mouth on request. Brain magnetic resonance image showed multiple high signal intensities in the insular cortex and basal ganglia, suggestive of sequelae of raised ICP due to hepatic failure (Fig. 1D) . The 
Discussion
We report the case of a patient with FHF and concomitant ICP crisis, which was successfully treated based on the information from JvO 2 monitoring.
Cerebral edema is a poor prognostic sign that renders patients at risk for subsequent tentorial herniation. [8] In patients, however, JvO 2 does not show any changes within the range of mild to moderate hemodilution (from 12 g/dL to 6 g/dL). [9] On admission, our patient's hemoglobin level was 12.1 g/dL and was remained mostly over 10 g/dL. Therefore, we do not think that JvO 2 fluctuation was simply due to a decrease in the hemoglobin level.
To summarize, we described the case of a patient with ICP crisis due to FHF. Multiple doses of osmotic agents and targeted temperature management were used to control ICP surges. Although the patient was treated under sedation, the specific cause of ICP crisis was identified based on the information from JvO 2 monitoring. JvO 2 monitoring is a substitute measure for global oxygen consumption and can be used for brain oxygen monitoring even in FHF patients with coagulopathy.
